{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T05:51:22Z","timestamp":1768369882001,"version":"3.49.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00108-025-01985-3","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T16:56:09Z","timestamp":1757004969000},"page":"123-128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Seltene Ursache einer \u201epure white cell aplasia\u201c (PWCA) bei einem 76-j\u00e4hrigen Patienten","Rare cause of pure white cell aplasia (PWCA) in a 76-year-old male patient"],"prefix":"10.1007","volume":"67","author":[{"given":"Milven","family":"Klka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evita","family":"Bothur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meike","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Chemnitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"issue":"19","key":"1985_CR1","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1056\/NEJM19830512308190","volume":"308","author":"LJ Levitt","year":"1983","unstructured":"Levitt\u00a0LJ, Ries\u00a0CA, Greenberg\u00a0PL (1983) Pure white-cell aplasia\u2014antibody-mediated autoimmune inhibition of granulopoiesis. N\u00a0Engl J Med 308(19):1141\u20131146. https:\/\/doi.org\/10.1056\/NEJM19830512308190","journal-title":"N Engl J Med"},{"key":"1985_CR2","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1186\/s12885-022-10090-9","volume":"22","author":"BC Park","year":"2022","unstructured":"Park\u00a0BC, Lee\u00a0AXT, Ye\u00a0F, Turker\u00a0I, Johnson\u00a0DB (2022) Immune checkpoint inhibitors and their impact on liver enzymes and attenuation. BMC Cancer 22:998. https:\/\/doi.org\/10.1186\/s12885-022-10090-9","journal-title":"BMC Cancer"},{"issue":"11","key":"1985_CR3","doi-asserted-by":"publisher","first-page":"e49473","DOI":"10.7759\/cureus.49473","volume":"15","author":"M Lutz","year":"2023","unstructured":"Lutz\u00a0M, Neumann\u00a0DT, Farf\u00e1n L\u00f3pez\u00a0F, Pfeiffer\u00a0T, Hirschb\u00fchl\u00a0K (2023) Pure white cell aplasia associated with long-term unprotected exposure to high concentrations of benzalkonium chloride and 2\u2011phenoxyethanol. Cureus 15(11):e49473. https:\/\/doi.org\/10.7759\/cureus.49473","journal-title":"Cureus"},{"issue":"22","key":"1985_CR4","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.3390\/cancers13225804","volume":"13","author":"F Autore","year":"2021","unstructured":"Autore\u00a0F, Pasquale\u00a0R, Innocenti\u00a0I et\u00a0al (2021) Autoimmune hemolytic anemia in chronic lymphocytic leukemia: a\u00a0comprehensive review. Cancers 13(22):5804. https:\/\/doi.org\/10.3390\/cancers13225804","journal-title":"Cancers"},{"issue":"23","key":"1985_CR5","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1182\/blood.V126.23.4169.4169","volume":"126","author":"M Tsang","year":"2015","unstructured":"Tsang\u00a0M, Chaffee\u00a0KR, Call\u00a0TG et\u00a0al (2015) Pure red cell aplasia (PRCA) in chronic lymphocytic leukemia (CLL): etiology, therapy, and outcomes. Blood 126(23):4169. https:\/\/doi.org\/10.1182\/blood.V126.23.4169.4169","journal-title":"Blood"},{"issue":"3","key":"1985_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1600-0609.2007.00901.x","volume":"79","author":"G Chakupurakal","year":"2007","unstructured":"Chakupurakal\u00a0G, Murrin\u00a0RJ, Neilson\u00a0JR (2007) Prolonged remission of pure white cell aplasia (PWCA) in a\u00a0patient with CLL, induced by rituximab and maintained by continuous oral cyclosporin. Eur J Haematol 79(3):271\u2013273. https:\/\/doi.org\/10.1111\/j.1600-0609.2007.00901.x","journal-title":"Eur J Haematol"},{"issue":"12","key":"1985_CR7","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.annonc.2022.10","volume":"33","author":"J Haanen","year":"2022","unstructured":"Haanen\u00a0J, Obeid\u00a0M, Spain\u00a0L, Carbonnel\u00a0F, Wang\u00a0Y, Robert\u00a0C, Lyon\u00a0AR, Wick\u00a0W, Kostine\u00a0M, Peters\u00a0S, Jordan\u00a0K, Larkin\u00a0J, Guidelines Committee\u00a0ESMO (2022) Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 33(12):1217\u20131238. https:\/\/doi.org\/10.1016\/j.annonc.2022.10","journal-title":"Ann Oncol"},{"issue":"2","key":"1985_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.14740\/jh1090","volume":"12","author":"T Ohashi","year":"2023","unstructured":"Ohashi\u00a0T, Takase-Minegishi\u00a0K, Maeda\u00a0A, Hamada\u00a0N, Yoshimi\u00a0R, Kirino\u00a0Y, Teranaka\u00a0H, Kunimoto\u00a0H, Hagihara\u00a0M, Matsumoto\u00a0K, Namkoong\u00a0H, Horita\u00a0N, Nakajima\u00a0H (2023) Incidence and risk of hematological adverse events associated with immune checkpoint inhibitors: a\u00a0systematic literature review and meta-analysis. J\u00a0Hematol 12(2):66\u201374. https:\/\/doi.org\/10.14740\/jh1090","journal-title":"J Hematol"},{"key":"1985_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000491","author":"J Lin","year":"2023","unstructured":"Lin\u00a0J, Rodriguez-Martinez\u00a0P, Oo\u00a0TH, Jorgensen\u00a0J, Rojas-Hernandez\u00a0CM (2023) Durvalumab-induced pure white cell aplasia. J\u00a0Immunother. https:\/\/doi.org\/10.1097\/CJI.0000000000000491","journal-title":"J Immunother"},{"issue":"2","key":"1985_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/CJI.0000000000000293","volume":"43","author":"I Finkel","year":"2020","unstructured":"Finkel\u00a0I, Sternschuss\u00a0M, Wollner\u00a0M, Shamai\u00a0S, Peled\u00a0N, Turgeman\u00a0I, Shochat\u00a0T, Dudnik\u00a0E (2020) Immune-related neutropenia following treatment with immune checkpoint inhibitors. J\u00a0Immunother 43(2):67\u201374. https:\/\/doi.org\/10.1097\/CJI.0000000000000293","journal-title":"J Immunother"},{"issue":"25","key":"1985_CR11","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.1182\/blood.2020009016","volume":"139","author":"MH Kroll","year":"2022","unstructured":"Kroll\u00a0MH, Rojas-Hernandez\u00a0C, Yee\u00a0C (2022) Hematologic complications of immune checkpoint inhibitors. Blood 139(25):3594\u20133604. https:\/\/doi.org\/10.1182\/blood.2020009016","journal-title":"Blood"},{"key":"1985_CR12","doi-asserted-by":"publisher","first-page":"4161679","DOI":"10.1155\/2016\/4161679","volume":"2016","author":"PG Kim","year":"2016","unstructured":"Kim\u00a0PG, Suh\u00a0J, Adelman\u00a0MW, Oduro\u00a0K, Williams\u00a0E, Brunner\u00a0AM, Kuter\u00a0DJ (2016) Pure white cell aplasia and necrotizing myositis. Case Rep Hematol 2016:4161679. https:\/\/doi.org\/10.1155\/2016\/4161679","journal-title":"Case Rep Hematol"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-01985-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-025-01985-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-01985-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T01:05:08Z","timestamp":1768352708000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-025-01985-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1985"],"URL":"https:\/\/doi.org\/10.1007\/s00108-025-01985-3","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Klka, E.\u00a0Bothur, M.\u00a0Clemens, C.\u00a0Lutz und J.\u00a0Chemnitz geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}